EW Q4 2017 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q4 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$889M+15.7% YoY

Gross Profit

$653M73.5% margin

Operating Income

$241M27.2% margin

Net Income

$36M4.0% margin

EPS (Diluted)

$0.06

QoQ Revenue Growth

+8.2%

Cash Flow

Operating Cash Flow

$364M

Free Cash Flow

$312M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$5.7B

Total Liabilities

$2.7B

Stockholders' Equity

$3.0B

Cash & Equivalents

$818M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$889M	$768M	+15.7%
Gross Profit	$653M	$557M	+17.2%
Operating Income	$241M	$209M	+15.6%
Net Income	$36M	$159M	-77.5%

Revenue Segments

Transcatheter Heart Valves

$519M58%

Surgical Heart Valve Therapy

$205M23%

Critical Care

$164M18%

Geographic Segments

UNITED STATES

$494M56%

Europe

$204M23%

JAPAN

$97M11%

Rest of World

$94M11%